Dermal connective tissue development in mice: An essential role for tenascin-X

Cell and Tissue Research

Volumn 323, Issue 3, 2006, Pages 465-474

  Egging, D F ^a   Van Vlijmen, I ^a   Starcher, B ^b   Gijsen, Y ^c   Zweers, M C ^a   Blankevoort, L ^c   Bristow, J ^d,e   Schalkwijk, J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

Collagen; Development; Ehlers Danlos syndrome; Elastin; Mouse (TNX knockout); Tenascin X

Indexed keywords

COLLAGEN FIBRIL; FIBRILLAR COLLAGEN; SCLEROPROTEIN; TENASCIN X; TROPOELASTIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTHROPATHY; ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; DERMIS; DEVELOPMENT; ELASTIC FIBER; FETUS DEVELOPMENT; IMMUNOFLUORESCENCE; KNOCKOUT MOUSE; MATURATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; SKIN; WILD TYPE;

ANIMALS; ANIMALS, NEWBORN; BIOMECHANICS; CONNECTIVE TISSUE; ELASTIN; FIBRILLAR COLLAGENS; JOINTS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SKIN; TENASCIN; TROPOELASTIN;

ANIMALIA;

EID: 32444431944     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00441-005-0100-5     Document Type: Article

References (38)

1. Andrikopoulos K, Suzuki HR, Solursh M, Ramirez F (1992) Localization of pro-alpha 2(V) collagen transcripts in the tissues of the developing mouse embryo. Dev Dyn 195:113-120
2. Bristow J, Tee MK, Gitelman SE, Mellon SH, Miller WL (1993) Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B. J Cell Biol 122:265-278
3. Burch GH, Gong Y, Liu W, Dettman RW, Curry CJ, Smith L, Miller WL, Bristow J (1997) Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat Genet 17:104-108
4. Elefteriou F, Exposito J, Garrone R, Lethias C (2001) Binding of tenascin-X to decorin. FEBS Lett 495:44-47
5. Elefteriou F, Exposito JY, Garrone R, Lethias C (1997) Characterization of the bovine tenascin-X. J Biol Chem 272:22866-22874
6. Elefteriou F, Exposito JY, Garrone R, Lethias C (1999) Cell adhesion to tenascin-X mapping of cell adhesion sites and identification of integrin receptors. Eur J Biochem 263:840-848
7. Exan RJ van, Hardy MH (1984) The differentiation of the dermis in the laboratory mouse. Am J Anat 169:149-164
8. Garrone R, Lethias C, LeGuellec D (1997) Distribution of minor collagens during skin development. Microsc Res Tech 38:407-412
9. Geffrotin C, Garrido JJ, Tremet L, Vaiman M (1995) Distinct tissue distribution in pigs of tenascin-X and tenascin-C transcripts. Eur J Biochem 231:83-92
10. Geffrotin C, Horak V, Crechet F, Tricaud Y, Lethias C, Vincent-Naulleau S, Vielh P (2000) Opposite regulation of tenascin-C and tenascin-X in MeLiM swine heritable cutaneous malignant melanoma. Biochim Biophys Acta 1524:196-202
11. Gijssen Y, Sierevelt I, Kooloos J, Blankevoort L (2004) Stiffness of the healing medial collateral ligament of the mouse. Connect Tissue Res 45:190-195
12. Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA, Fujimoto JG (1991) Optical coherence tomography. Science 254:1178-1181
13. Ikuta T, Ariga H, Matsumoto K (2000) Extracellular matrix tenascin-X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation. Genes Cells 5:913-927
14. Ikuta T, Sogawa N, Ariga H, Ikemura T, Matsumoto K (1998) Structural analysis of mouse tenascin-X: evolutionary aspects of reduplication of FNIII repeats in the tenascin gene family. Gene 217:1-13
15. Kyriakides TR, Zhu YH, Smith LT, Bain SD, Yang Z, Lin MT, Danielson KG, Iozzo RV, LaMarca M, McKinney CE, Ginns EI, Bornstein P (1998) Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol 140:419-430
16. Lethias C, Descollonges Y, Boutillon MM, Garrone R (1996) Flexilin: a new extracellular matrix glycoprotein localized on collagen fibrils. Matrix Biol 15:11-19
17. Lethias C, Elefteriou F, Parsiegla G, Exposito JY, Garrone R (2001) Identification and characterization of a conformational heparin-binding site involving two fibronectin type iii modules of bovine tenascin-X. J Biol Chem 276:16432-16438
18. Lindor NM, Bristow J (2005) Tenascin-X deficiency in autosomal recessive Ehlers-Danlos syndrome. Am J Med Genet A 135:75-80
19. Mao JR, Taylor G, Dean WB, Wagner DR, Afzal V, Lotz JC, Rubin EM, Bristow J (2002) Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition. Nat Genet 30:421-425
20. Martin SD, Patel NA, Adams SB, Roberts MJ, Plummer S, Stamper DL, Brezinski ME, Fujimoto JG (2003) New technology for assessing microstructural components of tendons and ligaments. Int Orthop 27:184-189
21. Matsumoto K, Saga Y, Ikemura T, Sakakura T, Chiquet ER (1994) The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C. J Cell Biol 125:483-493
22. Matsumoto K, Takayama N, Ohnishi J, Ohnishi E, Shirayoshi Y, Nakatsuji N, Ariga H (2001) Tumour invasion and metastasis are promoted in mice deficient in tenascin-X. Genes Cells 6:1101-1111
23. Matsumoto K, Takahashi K, Yoshiki A, Kusakabe M, Ariga H (2002) Invasion of melanoma in double knockout mice lacking tenascin-X and tenascin-C. Jpn J Cancer Res 93:968-975
24. Matsumoto K, Minamitani T, Orba Y, Sato M, Sawa H, Ariga H (2004a) Induction of matrix metalloproteinase-2 by tenascin-X deficiency is mediated through the c-Jun N-terminal kinase and protein tyrosine kinase phosphorylation pathway. Exp Cell Res 297:404-414
25. Matsumoto K, Sato T, Oka S, Inokuchi J, Ariga H (2004b) Comparison of the compositions of phospholipid-associated fatty acids in wild-type and extracellular matrix tenascin-X-deficient mice. Biol Pharm Bull 27:1447-1450
26. Matsumoto K, Sato T, Oka S, Orba Y, Sawa H, Kabayama K, Inokuchi J, Ariga H (2004c) Triglyceride accumulation and altered composition of triglyceride-associated fatty acids in the skin of tenascin-X-deficient mice. Genes Cells 9:737-748
27. Minamitani T, Ikuta T, Saito Y, Takebe G, Sato M, Sawa H, Nishimura T, Nakamura F, Takahashi K, Ariga H, Matsumoto K (2004) Modulation of collagen fibrillogenesis by tenascin-X and type VI collagen. Exp Cell Res 298:305-315
28. Niederreither K, DSouza R, Metsaranta M, Eberspaecher H, Toman PD, Vuorio E, DeCrombrugghe B (1995) Coordinate patterns of expression of type I and III collagens during mouse development. Matrix Biol 14:705-713
29. Peeters ACTM, Kucharekova M, Timmermans J, Berkmortel FWPJ van den, Boers GH, Novakova IRO, Egging D, Heijer M den, Schalkwijk J (2004) A clinical and cardiovascular survey of Ehlers-Danlos syndrome patients with complete deficiency of tenascin-X. Neth J Med 62:23-25
30. Schalkwijk J, Zweers MC, Steijlen PM, Dean WB, Taylor G, Van Vlijmen IM, Haren B van, Miller WL, Bristow J (2001) A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N Engl J Med 345:1167-1175
31. Starcher B (2001) A ninhydrin-based assay to quantitate the total protein content of tissue samples. Anal Biochem 292:125-129
32. Starcher B, Conrad M (1995) A role for neutrophil elastase in the progression of solar elastosis. Connect Tissue Res 31:133-140
33. Starcher B, Pierce R, Hinek A (1999) UVB irradiation stimulates deposition of new elastic fibers by modified epithelial cells surrounding the hair follicles and sebaceous glands in mice. J Invest Dermatol 112:450-455
34. Starcher B, Aycock RL, Hill CH (2005) Multiple roles for elastic fibers in the skin. J Histochem Cytochem 53:431-443
35. Waard JWD de, Wobbes T, Deman BM, Linden CJ van der, Hendriks T (1995) Postoperative levamisole may compromise early healing of experimental intestinal anastomoses. Br J Cancer 72:456-460
36. Zweers MC, Bristow J, Steijlen PM, Dean WB, Hamel BC, Otero M, Kucharekova M, Boezeman JB, Schalkwijk J (2003) Haploinsufficiency of TNXB is associated with hypermobility type of Ehlers-Danlos syndrome. Am J Hum Genet 73:214-217
37. Zweers MC, Vlijmen-Willems IM, Van Kuppevelt TH, Mecham RP, Steijlen PM, Bristow J, Schalkwijk J (2004) Deficiency of tenascin-X causes abnormalities in dermal elastic fiber morphology. J Invest Dermatol 122:885-891
38. Zweers MC, Peeters ACTM, Graafsma S, Kranendonk S, Vliet JA van der, Heijer M den, Schalkwijk J (2005) A high tenascin-X serum concentration is a risk indicator for abdominal aortic aneurysm. Circulation (in press)